Johnson & Johnson suffered a major setback Dec. 14 in its battle to defend the safety of Johnson’s Baby Powder on the global PR front – in addition to the courts – in the form of a Reuters report suggesting the firm has been concealing asbestos-tainted talc risks from the public for decades.
The firm’s stock plummeted following the report’s publication and remains down roughly 12% as of mid-morning trading Dec. 19.





